FindTrial
Sign In

CMRI

DEVICE4 trials

Sponsors

US Department of Veterans Affairs, National Institute of Allergy and Infectious Diseases (NIAID), Aspire Foundation, Assistance Publique - Hôpitaux de Paris

Conditions

AcromegalyAtrial FibrillationCoronary ArteriosclerosisCoronary Artery Bypass GraftCryoablationMyocardial RevascularizationSystemic Sclerosis-Associated PAH

Phase 1

Stem Cell Therapy as Adjunct to Revascularization
WithdrawnNCT00463853
US Department of Veterans AffairsCoronary Arteriosclerosis, Coronary Artery Bypass Graft, Myocardial Revascularization
Start: 2007-08-31End: 2009-10-31Updated: 2014-06-11

Phase 2

Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
CompletedNCT01086540
National Institute of Allergy and Infectious Diseases (NIAID)Systemic Sclerosis-Associated PAH
Start: 2011-06-24End: 2019-12-15Updated: 2023-02-21

Phase 4

A Pilot Investigation Detecting Cryoablation Scar by 3D Late Gadolinium Enhancement
CompletedNCT02875730
Aspire FoundationAtrial Fibrillation, Cryoablation
Start: 2016-12-13End: 2018-04-27Target: 10Updated: 2018-06-29

Unknown Phase

Cardiac (CMRI) Assessment of Acromegaly
CompletedNCT02948322
Assistance Publique - Hôpitaux de ParisAcromegaly
Start: 2014-12-31End: 2019-02-28Updated: 2019-05-15

Related Papers

Increase in intracellular and extracellular myocardial mass in patients with acromegaly: a cardiac magnetic resonance imaging study
European Journal of Endocrinology2023-08-0110 citations
Safety and Efficacy of B-Cell Depletion with Rituximab for the Treatment of Systemic Sclerosis–associated Pulmonary Arterial Hypertension: A Multicenter, Double-Blind, Randomized, Placebo-controlled Trial
American Journal of Respiratory and Critical Care Medicine2021-03-02170 citations